FinscoFinsco

Guardian Pharmacy Services (US.GRDN)

Capital Allocation Audit · Period: 2018 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.GRDN · YoY: 2026 Q1 vs 2025 Q1

MetricValueYoY
FCF Conversion17.2%↓
ROE6.0%→
Cash Conversion45.6%↓
D/E Ratio0.17↑
Gross Margin22.7%↑
US.GRDN (Guardian Pharmacy Services) | YoY: 2026 Q1 vs 2025 Q1


Metric           Value  YoY
---------------------------
FCF Conversion   17.2%    ↓
ROE               6.0%    →
Cash Conversion  45.6%    ↓
D/E Ratio         0.17    ↑
Gross Margin     22.7%    ↑
Key Metrics
US.GRDN (Guardian Pharmacy Services) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY
---------------------------
FCF Conversion 17.2% ↓
ROE 6.0% →
Cash Conversion 45.6% ↓
D/E Ratio 0.17 ↑
Gross Margin 22.7% ↑

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies